3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
44
Prostatic Neoplasms, Castration-Resistant
2
Neoplasm Metastasis
2
Stage II Prostate Adenocarcinoma
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Prostate Cancer Metastatic Disease
1
Prostate Adenocarcinoma
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms
1
Neoadjuvant Therapy
1
Low Risk Prostate Cancer
1
High Risk Prostate Cancer
1
Hematologic Neoplasms
1
Castration Levels of Testosterone
1
Carcinoma, Small Cell
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
apalutamide
1
Receptors, Androgen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
High Risk Prostate Cancer
×
apalutamide
×
Clear all
NCT06758882
2025-01-06
STAPLE
A.O.U. Città della Salute e della Scienza
Phase 2
Recruiting
94 enrolled